Cameron John Reynolds - Oct 13, 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Cameron John Reynolds
Stock symbol
VNRX
Transactions as of
Oct 13, 2022
Transactions value $
$0
Form type
4
Date filed
10/14/2022, 04:08 PM
Previous filing
Oct 6, 2022
Next filing
Jan 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +15.6K +1.12% $0.00 1.41M Oct 13, 2022 Direct F1
holding VNRX Common Stock 1.01M Oct 13, 2022 By Concord International, Inc. F2
holding VNRX Common Stock 34.1K Oct 13, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2022, the reporting person was awarded 89,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 15,575 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 5,192 units, 5,192 units, and 5,191 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.